LOC283547 inhibitors constitute a distinct chemical class designed to selectively target and modulate the function of the non-coding RNA LOC283547. As a member of the extensive family of non-coding RNAs, LOC283547 is categorized as a long intergenic non-protein coding RNA (lincRNA). LincRNAs, despite lacking protein-coding potential, have garnered attention for their diverse roles in cellular processes. The inhibitors developed for LOC283547 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular milieu and potentially influence various cellular regulatory networks.
The molecular architecture of LOC283547 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. This interaction holds the potential to impact the regulatory functions that LOC283547 may exert in cellular processes. In laboratory research, these inhibitors serve as essential tools, enabling scientists to probe the nuanced functions of LOC283547 in various cellular contexts. By manipulating the function of LOC283547, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC283547 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, which could decrease the transcription of LINC00639. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II that would reduce lncRNA transcription. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to intercalate into DNA and RNA, which could affect the transcription of various RNAs, including LINC00639. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II transcriptional elongation and could reduce LINC00639 levels. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Inhibits cyclin-dependent kinases and affects transcription regulation, potentially impacting LINC00639 expression. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
A BET bromodomain inhibitor that might influence the transcription of LINC00639 by altering chromatin accessibility. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Blocks initiation of translation and could indirectly affect the stability of lncRNA transcripts. | ||||||
C646 | 328968-36-1 | sc-364452 sc-364452A | 10 mg 50 mg | $265.00 $944.00 | 5 | |
A selective inhibitor of histone acetyltransferase p300, could result in altered expression of lncRNAs. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptidyl transferase activity of the ribosome and affects protein synthesis, potentially influencing lncRNA expression. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
Inhibits RNA polymerase I, which primarily transcribes rRNA, but could have off-target effects on lncRNA transcription. | ||||||